Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD

Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease

(2010) M. C. Hu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

(2010) Hisashi Hasegawa et al.   KIDNEY INTERNATIONAL

Vascular Calcification: The Killer of Patients with Chronic Kidney Disease

(2009) M. Mizobuchi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The emerging role of phosphate in vascular calcification

(2009) Cecilia M. Giachelli   KIDNEY INTERNATIONAL

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients

(2009) G. Jean et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Vitamin D Receptor Activators Can Protect against Vascular Calcification

(2008) S. Mathew et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKD

(2008) S. Mathew et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Cinacalcet suppresses calcification of the aorta and heart in uremic rats

(2008) Takehisa Kawata et al.   KIDNEY INTERNATIONAL

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats

(2007) I. Lopez et al.   KIDNEY INTERNATIONAL